Fellowship Aims To Boost Study In Broad Discipline

A West German chemical com-pany's United States subsidiary intends to make its presence known in North America over the next five years by offering a bonanza to grad students at U.S. universities. The Henkel Corp., which opened its U.S. research facility in Ambler, Pa., last fall, will award at least four two-year fellowships of $20,000 per year to third- and fourth-year doctoral candidates in colloid and surface chemistry. The discipline, which focuses on the interaction between particles and

Written byBarbara Spector
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

A West German chemical com-pany's United States subsidiary intends to make its presence known in North America over the next five years by offering a bonanza to grad students at U.S. universities. The Henkel Corp., which opened its U.S. research facility in Ambler, Pa., last fall, will award at least four two-year fellowships of $20,000 per year to third- and fourth-year doctoral candidates in colloid and surface chemistry. The discipline, which focuses on the interaction between particles and surfaces, is relatively young, but nonetheless crucial to industry.

David Devore, a senior member of Henkel's technical staff and one of the three scientists who will be selecting the recipient of the first Henkel Fellowship, acknowledges that the $20,000 award - intended to cover equipment and travel expenses for the recipient, as well as a salary - is "up there with the most funding available" to graduate students. The largess, he says, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies